{"id":57,"date":"2021-03-07T21:18:09","date_gmt":"2021-03-07T20:18:09","guid":{"rendered":"http:\/\/wtspatent.pl\/?page_id=57"},"modified":"2026-02-03T13:01:33","modified_gmt":"2026-02-03T12:01:33","slug":"spory-patentowe-w-farmacji","status":"publish","type":"page","link":"https:\/\/wtspatent.pl\/en\/zakres-uslug\/spory-patentowe-w-farmacji\/","title":{"rendered":"Pharmaceutical Patent Litigation"},"content":{"rendered":"<p><strong>WTS Patent Attorneys has specialised in legal advice relating to the identification of and minimizing patent risks inherent in the market entry of pharmaceuticals. <\/strong><\/p>\n<p><strong>Our team has conducted many court processes before the Polish Patent Office and civil courts, in cases concerning patent invalidation as well as matters concerning their infringement.<\/strong><\/p>\n<p>Our experiences:<\/p>\n<p><strong>Alendronate<\/strong> patent PL 195 272 &#8211; invalidation action, non-infringement declaratory action<\/p>\n<p><strong>Venlafaxine<\/strong> patent PL 188 444 &#8211; non-infringement declaratory action<\/p>\n<p><strong>Quetiapine<\/strong> patent PL189887 &#8211; invalidation action<\/p>\n<p><strong>Repaglinide<\/strong> patent PL170210 &#8211; invalidation action<\/p>\n<p><strong>Oxaliplatine<\/strong> patent PL197948 &#8211; invalidation action<\/p>\n<p><strong>Montelukast<\/strong> patent PL 178671 &#8211; invalidation action, non-infringement declaratory action, infringement action<\/p>\n<p><strong>Dorzolamide<\/strong> patent PL 176 373 &#8211; non-infringement declaratory action<\/p>\n<p><strong>Esomeprazole<\/strong> patents: PL 178 994, PL 180 395, PL 180 598 &#8211; invalidation actions, non-infringement declaratory action, infringement action<\/p>\n<p><strong>Docetaxel<\/strong> patent PL 173 951 &#8211; invalidation action<\/p>\n<p><strong>Drospirenone<\/strong> + <strong>Ethynyloestradiol<\/strong> patent PL 199028 &#8211; infringement action, invalidation action<\/p>\n<p><strong>Herceptin<\/strong> patent PL202369 &#8211; invalidation action<\/p>\n<p><strong>Tiotropium<\/strong> patent PL209520 &#8211; opposition action<\/p>\n<p><strong>Clopidogrel + Acetylsalicylic\u00a0acid\u00a0<\/strong>patent PL 187292 \u2013 invalidation action<\/p>\n<p><strong>Capecitabine\u00a0<\/strong>SPC for patent PL174100 \u2013 invalidation action<\/p>\n<p><strong>Tropenole\u00a0<\/strong>patent PL 209 520 \u2013 opposition action<\/p>\n<p><strong>Budesonide + Formeterol\u00a0<\/strong>patent PL190782 \u2013 invalidation action<\/p>\n<p><strong>Rituximab\u00a0<\/strong>patent PL 200 134 \u2013 invalidation action<\/p>\n<p><strong>Valsartan + Amlodipine\u00a0<\/strong>patent PL 194604 \u2013 invalidation action<\/p>\n<p><strong>Formulation\u00a0for\u00a0inhalation\u00a0<\/strong>patent PL\/EP1699434 \u2013 infringement action<\/p>\n<p><strong>DMF<\/strong> patent EP\/PL2653873 T3 \u2013 invalidation action<\/p>\n<p><strong>Rivaroxaban<\/strong> patent PL\/EP 1845961 \u2013 invalidation action<\/p>\n<p><strong>Apixaban<\/strong> patent PL 204263 B1\u00a0 + SPC \u2013 invalidation action<\/p>\n<p><strong>Sacubitril-valsartan<\/strong> patent PL 212318 B1 + SPC \u2013 invalidation action<\/p>","protected":false},"excerpt":{"rendered":"<p>WTS Patent Attorneys has specialised in legal advice relating to the identification of and minimizing patent risks inherent in the market entry of pharmaceuticals. Our team has conducted many court processes before the Polish Patent Office and civil courts, in cases concerning patent invalidation as well as matters concerning their infringement. Our experiences: Alendronate patent [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2160,"parent":20,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"protect_children":false,"footnotes":""},"_links":{"self":[{"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages\/57"}],"collection":[{"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/comments?post=57"}],"version-history":[{"count":4,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages\/57\/revisions"}],"predecessor-version":[{"id":3339,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages\/57\/revisions\/3339"}],"up":[{"embeddable":true,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages\/20"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/media\/2160"}],"wp:attachment":[{"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/media?parent=57"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}